Sofinnova sells Corvidia Therapeutics for $2.1bn
Sofinnova Partners has sold Corvidia Therapeutics to Novo Nordisk for $2.1 billion.
11 June 2020•3 mins read
Sofinnova Partners has sold Corvidia Therapeutics to Novo Nordisk for $2.1 billion.
Arcline’s Signia Aerospace to acquire JLL Partners’ Heads Up Technologies
8 minutes ago · 1 min read
Ansor’s Corvero acquires Northern Ireland aerospace tooling specialist Datum Design
32 minutes ago · 2 mins read
HIG Capital’s Vernacare adds UK medical device businesses Bailey and ASep
3 hours ago · 2 mins read
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
19 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
19 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
20 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
20 hours ago · 2 mins read
